Medication- and treatment-associated dysregulation patterns

What records in this area tend to contain

These are descriptions of records, not diagnostic criteria. Recognising several of them does not mean you have a condition, and none of them is being asserted about you.

• A datable turning point coinciding with a drug course, taper, or procedure
• Repeated antimicrobial exposure across years, with cumulative rather than single-event change
• Long-term PPI or H2 blocker use preceding digestive or nutrient findings
• Post-surgical onset, including after abdominal or gynaecological procedures
• Symptoms spanning tendon, nerve, autonomic, GI and cognitive domains after a single exposure
• Clinicians divided on whether the intervention is relevant at all

The analytical work on a case like this

• A precise exposure-and-symptom timeline built from records rather than recollection alone
• Known and hypothesised mechanisms for the specific agents involved, graded by evidence strength
• Microbiome, mitochondrial, connective tissue and barrier considerations where the agent supports them
• What was already changing before the exposure, which is the most commonly missed detail
• Nutrient and absorption consequences of long-term acid suppression, where relevant
• Whether subsequent course fits an injury model, a persistence model, or neither

What the work is trying to answer

These are the questions the reconstruction is built around. They are questions, not promises — some records answer them clearly and some do not, and the written synthesis says which.

• How strong is the temporal case once the record is reconstructed rather than remembered?
• Which proposed mechanisms are established, which are plausible, and which are speculation?
• Is there a pre-exposure trajectory that the intervention narrative has obscured?
• What follow-up question would most usefully separate injury from coincidence?

What would argue against the leading reading

Every synthesis states the alternatives it could not exclude. For this area, the most important ones are:

• An underlying condition that prompted the treatment and continued independently of it
• An infection or illness treated by the agent, with the illness rather than the drug driving the course
• Recall and attribution effects, which are strong for datable events
• A second, unrelated process beginning in the same period
• Withdrawal or discontinuation physiology rather than persistent injury

Related reading on this site

• Drug–microbiome interactions
• Chronic gut dysbiosis
• Interaction library

• MCAS, histamine and multisystem reactivity

  For reactivity that spans foods, medications and environments, where stabilisers have helped partially and the trigger list keeps growing.

• Mold, CIRS-related and environmental patterns

  For records built around a suspected exposure, where mycotoxin panels, inflammatory markers and competing frameworks have produced more conflict than clarity.

• Complex food and chemical sensitivity

  For shrinking diets and growing reaction lists, where each new restriction buys less relief than the last.

All Areas of Analysis →